Call us:

4D Proteomics Service

Deeper Coverage · Higher Confidence · Cohort-Ready Data

Facing challenges with incomplete proteome coverage, batch-to-batch variability, or low-abundance proteins?

Our TIMS-enabled 4D Proteomics workflows combine trapped ion mobility spectrometry with ion-mobility DIA to deliver thousands of proteins per run, minimized missing values, and confident PTM site localization—without increasing sample demand.

From biomarker discovery to mechanism studies, Creative Proteomics provides reliable, scalable, and publication-ready proteomics data to accelerate research decisions.

  • 7,000–9,000 proteins/run for comprehensive pathway coverage
  • <1% FDR & <5% missing values → reproducible, high-confidence quantitation
  • Scalable 4D-DIA workflows adaptable from pilot studies to large cohorts
  • Site-level PTM analysis (phosphorylation, ubiquitination, acetylation, glycosylation)
  • Discovery-to-targeted pipeline with seamless transition to PRM/MRM with ion-mobility

Get a Quote

What Is 4D Proteomics?

4D Proteomics augments high-resolution LC–MS/MS with TIMS and ion-mobility–enabled DIA acquisition, separating peptide signals along four orthogonal axes:

  • m/z (mass-to-charge)
  • Retention time (chromatographic)
  • Intensity (quantitative signal)
  • Ion mobility / CCS (gas-phase separation from TIMS)

Adding the ion-mobility dimension decongests complex spectra, improves precursor selection (higher ion utilization), and enhances peptide feature alignment across runs—enabling deeper identification and more complete, reproducible quantification without increasing sample consumption.

Content Guide

  • Why 4D Proteomics?
  • What We Solve
  • Why Creative Proteomics
  • 4D Proteomics Solutions
  • 4D → Targeted (How They Work Together)
  • Workflow
  • Platforms & Methods
  • Sample Requirements
  • Deliverables

Why 4D Proteomics

Traditional DDA and standard DIA workflows can face limitations when analyzing complex biological samples: under-sampling, co-fragmentation, and missing values that compromise data completeness. 4D Proteomics integrates trapped ion mobility spectrometry (TIMS) with ion-mobility–enabled DIA acquisition, creating an additional gas-phase separation dimension. This design increases ion utilization, reduces spectral crowding, and enhances peptide feature alignment, which together provide more confident identifications and robust quantification.

When to Choose 4D Proteomics

  • Large or multi-batch label-free cohort studies requiring consistent quantitation across runs.
  • Complex or heterogeneous matrices such as plasma, serum, FFPE tissues, or primary cells where conventional DIA struggles with interference.
  • Projects focused on low-abundance proteins or subtle biological changes that demand improved sensitivity and selectivity.
  • Non-model organisms or systems lacking established spectral libraries, where library-free and hybrid strategies can still ensure deep coverage.
  • PTM-focused research where site localization accuracy is essential to interpret regulatory mechanisms.

What Problems Does 4D Proteomics Solve?

From complex matrices to PTM analysis, see how 4D proteomics addresses real research challenges.

Heterogeneous and Complex Matrices

TIMS-guided separation and matrix-aware acquisition turn plasma/serum, FFPE tissues, and primary cells into cleaner, interpretable proteome readouts.

Low-Abundance Protein Detection

4D selectivity lifts scarce peptides above background, revealing faint expression shifts so small effect sizes can be prioritized confidently.

Large-Scale and Multi-Batch Studies

Label-free studies across dozens or hundreds of runs often suffer from variability and missing data. 4D Proteomics applies IM-aware alignment and standardized ion-mobility DIA windows, producing harmonized quant tables with typically <2–5% protein-level missingness.

Post-Translational Modification Analysis

Targeted enrichments plus TIMS-enhanced selectivity deliver site-level phospho/ubiquitin/acetyl/glyco assignments with clear evidence for pathway analysis.

Projects Without Established Spectral Libraries

Projects can begin immediately in library-free mode, avoiding delays. When deeper coverage is needed, hybrid libraries can be added, giving flexibility without restarting the workflow.

From Discovery to Targeted Verification

Datasets can be retrospectively mined and smoothly transitioned into targeted panels (prm/mrm), reducing reruns and ensuring a faster route from global discovery to focused validation.

Advantages of Our 4D Proteomics

Comprehensive Protein Profiling

7,000–9,000 Proteins / Run

Profile thousands of proteins per experiment, providing a broad and unbiased view of biological pathways.

Quantitative Precision

Protein CV ≤10–15%

Deliver stable and reproducible label-free quantitation across large-scale studies.

Dynamic Range

~5–6 Orders of Magnitude

Detect proteins across wide abundance levels to capture subtle biological differences.

Data Completeness

<2–5% Missingness

IM-aware alignment minimizes missing values and increases cross-run comparability.

Mass Accuracy & Stability

~1–2 ppm; TIMS/RT R² ≥0.99

Strict calibration ensures high-confidence identifications and consistent reproducibility.

PTM Site-Level Confidence

Phospho • Ubiquitin • Acetyl • Glyco

TIMS-enhanced selectivity supports accurate localization of diverse PTM sites.

4D Proteomics Tailored to Your Needs

Choose from discovery, PTM, targeted, label-free, glyco, or metaproteomics modules.

Discovery 4D-DIA (ion-mobility DIA)

  • Global, label-free quantification with a library-free start.
  • Expandable into hybrid spectral libraries and optional fractionation for deeper proteome coverage.

Targeted 4D Quant (prm-PASEF / mrm-PASEF)

  • High-selectivity verification panels for pathway confirmation and bioprocess CQAs (research use).
  • Back-calculations from discovery datasets to design fit-for-purpose assays.

PTM-4D Proteomics (Phospho, Ubiquitin, Acetyl, Glyco)

  • Enrichment workflows for phosphorylation (TiO₂/IMAC), ubiquitin-remnant (K-ε-GG), acetylation, and glycosylation.
  • Delivers stringent site localization, motif analysis, and kinase/substrate inference.
  • Supports combined phospho–glyco crosstalk designs for pathway-level insight.

4D Label-Free Proteomics

  • End-to-end 4D workflow optimized for depth, reproducibility, and input flexibility.
  • Supports low-input samples with robust cleanup and IM-aware alignment for consistency.

4D Glycosylation Proteomics

  • Comprehensive analysis of glycosites and glycoforms, including O-GlcNAc mapping and N-/O-glycoform profiling.
  • Optional combined phospho–glyco studies to explore regulatory crosstalk.

4D-LFQ Metaproteomics

  • Large-scale community-level proteomics with cohort stability across diverse samples.
  • Includes optional taxonomy and functional annotations for microbiome and environmental research.

Discovery 4D-DIA vs Targeted PRM/MRM with ion-mobility — Decision Guide

Match your research goals with the right acquisition strategy for the best outcomes.

Study Goal Recommended Path Rationale Typical Output
Global profiling / hypothesis generation Discovery 4D-DIA Maximize IDs and coverage; robust across cohorts Protein/peptide matrices; pathway insights
Confirm specific pathways or markers Targeted PRM/MRM with ion-mobility High selectivity and precision on curated panels Panel-level quant; longitudinal comparability
PTM landscape (phospho, ubiquitin, acetyl, glyco) PTM-4D modules Enrichment + 4D selectivity improves site-level confidence Localized PTM site tables; motif/kinase analyses
Bioprocess comparability / HCP profiling 4D-DIA ± targeted follow-up Cohort-scale consistency; panel verification for CQAs Batch reports, control charts, verified targets

Step-by-Step 4D Proteomics Workflow

At Creative Proteomics, our 4D proteomics workflow is tailored to deliver reliable data—from exploratory profiling to targeted validation. Each step is optimized for reproducibility, depth, and clarity.

1
Consultation & Study Design

Define biological questions, matrices, effect sizes, and statistical power; choose discovery vs targeted vs PTM modules.

2
Sample Preparation & QC

Lysis and digestion under detergent-aware protocols; cleanup via S-Trap / SP3 / FASP-like workflows; spike-in iRT and process controls.

3
Acquisition (TIMS ion-mobility DIA / DDA with ion-mobility separation / prm-PASEF)

Optimized ion-mobility windows and DIA isolation schemes tuned to matrix complexity and throughput targets.

4
Data Processing & FDR Control

Library-free or hybrid spectral libraries; 1% FDR at PSM/peptide/protein levels; peptide uniqueness filters per scope.

5
Quantitation & Statistics

Normalization, missing-value handling, differential expression, variance modeling; batch harmonization with bridge samples (if multi-batch).

6
Biological Interpretation & Reporting

Pathway/GO/Reactome enrichment, GSEA-style analysis, clustering/PCA/UMAP; publication-ready figures and an auditable QC pack.

Project Consultation
Set goals; choose the best 4D strategy and ion-mobility DIA plan
Sample Preparation & QC
Matrix-specific prep; strict quality controls for reproducibility
4D-MS Acquisition
TIMS + PASEF capture; standardized ion-mobility DIA windows
Data Processing & Quantification
Library-free/hybrid; IM-aware alignment
Bioinformatics Analysis
Differential results, pathways, and PTM site evidence
Comprehensive Reporting
Raw + quantitative tables + QC; tool-ready exports
  • Library-free → hybrid: start immediately, deepen coverage as needed
  • Cohort-grade consistency: IM-aware alignment and pooled QC/bridge strategy
  • Low-input options: conserve material without sacrificing depth
  • Expert support: guidance from study design to interpretation

What Makes Our 4D Proteomics Service Stand Out?

SCIEX TripleTOF 6600+

timsTOF Pro / timsTOF Pro 2 (Bruker)

Technology: Trapped Ion Mobility Spectrometry (TIMS) combined with parallel ion accumulation with serial fragmentation.

Acquisition Strategy: ion-mobility DIA for discovery proteomics, with optional PRM/MRM with ion-mobility for validation.

Key Parameters:

  • Duty cycle > 100 Hz
  • Ion mobility resolution R > 200
  • Mass accuracy 1–2 ppm

Strengths: 4D separation reduces interference, enhances ion utilization, and delivers deeper coverage with fewer missing values.

Thermo Scientific Orbitrap Exploris 480
Thermo Scientific Q Exactive HF-X

Orbitrap Exploris 480 / Fusion Lumos (Thermo Scientific)

Technology: High-field Orbitrap mass analyzer with quadrupole selection.

Acquisition Strategy: DIA or hybrid library-free approaches for large-cohort discovery studies.

Key Parameters:

  • Resolution up to 480,000 at m/z 200 (Exploris)
  • Mass accuracy < 2 ppm
  • Dynamic range ~ 5–6 orders of magnitude

Strengths: Excellent mass accuracy and stability, well-suited for cohort-scale proteomics, PTM studies, and quantitative discovery.

Data Acquisition Approach

  • DIA (Data-Independent Acquisition, incl. ion-mobility DIA): Captures all detectable precursors, minimizing missing values and improving reproducibility.
  • Library-Free or Hybrid Modes: Ensure high-quality quantitation even without existing spectral libraries, making the approach versatile for both model and non-model organisms.

4D Proteomics: Sample Requirements and Preparation

Buffer compatibility: Please avoid strong detergents and chaotropes in final submissions; we perform cleanup as needed.

QC controls: We incorporate system-suitability standards (iRT, reference digests) and recommend pooled QC + biological replicates.

Matrix / Type Recommended Input (typical) Storage & Handling
Cells ≥ 1–5 × 10⁶ cells (total protein equivalent) Snap-freeze pellet; avoid residual detergents and high salt
Tissue (fresh/frozen) ≥ 20–50 mg wet weight Snap-freeze; minimize ischemia time; aliquot to avoid re-freeze
FFPE 5–10 curls or sections (thickness per lab SOP) Store at ambient in low humidity; provide H&E where available
Serum/Plasma ≥ 50–200 µL Freeze promptly; avoid repeated freeze–thaw
CSF/Urine/Other ≥ 200–500 µL (matrix-dependent) Clarify via low-speed spin; freeze supernatant
Organoids/Microdissected As available; consult for low-input workflows Carrier strategies and peptide boosts available

Not sure whether your samples meet the requirements?
Contact us — we're happy to help design the best strategy for your 4D proteomics study.

What You'll Receive from Our 4D Proteomics Service

Data, insights, and publication-ready results for your research

Bar chart showing protein and peptide identification counts across multiple runs.

Single 4D-DIA runs identify more than 7,000 proteins and tens of thousands of peptides, demonstrating deep proteome coverage.

Scatter plot of replicate protein intensities with high correlation and R² annotation.

High correlation between biological replicates (R² > 0.95) confirms the stability and reproducibility of quantitation.

Box plot of percentage missing values per batch across samples.

Across-batch missing values remain below 5%, highlighting the data completeness of 4D-DIA.

Volcano plot showing fold change vs p-value, with significant proteins marked.

Differential expression analysis highlights significantly up- and down-regulated proteins, visualizing biological contrasts.

Bubble plot of top enriched pathways showing -log10(p-value) on the x-axis, pathways on the y-axis, bubble size for protein count, and color scale for FDR.

Bubble plot of enriched GO/KEGG pathways, where bubble size represents protein count and color reflects FDR significance.

Heatmap of protein expression patterns across control and treated sample groups.

Clustered heatmap of protein expression illustrates group differences between control and treated samples.

Discuss Your Project

Raw Data

  • Native instrument files (e.g., .d from timsTOF, Orbitrap RAW) with acquisition logs.

Processed Quantitative Tables

  • Protein- and peptide-level intensity or LFQ matrices.
  • PTM site tables with localization probabilities (if applicable).

Spectral Libraries (if required)

  • Library-free or hybrid libraries generated during the project.

Quality Control Pack

  • Summary of identification depth, CV distributions, missing values, retention time and ion mobility stability.

Bioinformatics & Reporting

  • Statistical analysis results (differential expression, clustering, PCA/UMAP).
  • Pathway enrichment and biological interpretation (GO, KEGG, Reactome).
  • Publication-ready figures (volcano plots, heatmaps, pathway diagrams).
How many biological replicates do you recommend for discovery studies?
Typically ≥3 per group for basic comparisons; more if effect sizes are small. We can run a quick power check (based on expected variance) to recommend the right n and blocking scheme.
How do you design batches to control variability?
We randomize run order, place pooled QC/bridge samples at regular intervals, and keep method settings fixed. If a QC fails predefined thresholds (e.g., iRT/IM drift), we pause and re-run affected samples.
How are protein groups built and reported?
We prioritize proteotypic peptides and transparent grouping rules. Shared peptides are flagged, and we provide both peptide-level and protein-group tables so you can choose the aggregation level.
What normalization and imputation strategies do you use?
We default to intensity-based normalization with IM-aware alignment. For inference, we separate MCAR vs MNAR missingness and can apply left-censored imputation (e.g., MinDet/QRILC). You receive both imputed and non-imputed matrices.
Can you handle plasma/serum without high-abundance depletion?
Yes. 4D-DIA performs well on neat plasma/serum. If your targets are extremely low-abundance, we'll discuss depletion vs no-depletion trade-offs (coverage vs quant comparability) before the study begins.
What if my sample contains detergents, salts, or paraffin (FFPE)?
We use detergent-aware lysis and robust cleanup (S-Trap/SP3/FASP-like). For FFPE, we optimize deparaffinization and retrieval; for salt or lipid carryover, we adjust cleanup and LC settings to protect depth and chromatography.
Do you support alternative proteases (beyond trypsin)?
Yes—Lys-C, Glu-C, Asp-N, chymotrypsin, or multi-protease strategies, when biology or PTM mapping benefits from broader sequence coverage.
How are spectral libraries built if we start library-free?
We can keep the entire study library-free, or add a hybrid library later using gas-phase fractionation or fractionated DDA on pooled material—without restarting your pipeline.
Can you re-process my data later with a new library or new thresholds?
Yes. Our pipelines are version-locked for traceability, and we can re-run with updated libraries or parameters. We document all changes so outputs remain auditable.
How do you control false discovery at the PTM site level?
We apply site-localization scoring and report site-level probabilities in addition to peptide/protein FDR. Ambiguous sites are flagged so you can filter by confidence.
Do you support cross-platform or legacy data integration (e.g., older DDA with new 4D-DIA)?
We can align across platforms using bridge samples and compatible normalization, then deliver a harmonized matrix with flags for data provenance.
Which output formats/software are supported?
We provide .csv/.tsv tables plus exports compatible with common tools (e.g., DIA-NN, Spectronaut, Skyline, MSstats, Perseus). Figures are delivered as PNG/SVG on request.
Can you do metaproteomics with taxonomic assignment?
Yes. For 4D-LFQ metaproteomics, we support customizable reference sets (e.g., GTDB/UniProt subsets) and lowest common ancestor taxonomy with functional annotation.
How do you mitigate carryover or contamination (e.g., keratins)?
We use strict blank runs, needle/valve wash, and contamination tracking. Any flagged proteins are reported so you can exclude them downstream.
What statistical tests do you use for differential analysis?
We support moderated models and multiple-testing control (e.g., Benjamini–Hochberg). You can choose protein- or peptide-level inference; both are documented in the report.
Can targeted panels be designed directly from my discovery dataset?
Yes. We back-calculate proteotypic transitions from your 4D-DIA results to build PRM/MRM with ion-mobility panels, then verify performance on your matrix.
* For Research Use Only. Not for use in the treatment or diagnosis of disease.

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized study plan to meet your requests. You can also send us an email to info@creative-proteomics.org for inquiries.

Online Inquiry

×
LOGO

Specializing in proteomics, Creative Proteomics offers cutting-edge protein analysis services. Our distinctive approach revolves around harnessing the power of DIA technology, enabling us to deliver precise and comprehensive insights that drive advancements in research and industry.

  • USA
  • Tel:
  • Fax:
  • Email:
  • Germany
Copyright © 2025 Creative Proteomics. All rights reserved.